It is reported that upregulation of Cyr61 could aggravate the development and metastasis of breast cancer [33]; however, interestingly, it is also noted that Cyr61 has low expressions in metrocarcinoma [32], cervical cancer [35, 36], and lung cancer [34, 37]. The gene discussed is CCN1; the disease is lung carcinoma.